Weight Watchers Reports Mixed Q1 2026 Results: Clinical Growth Offsets Behavioral Decline
Event summary
- Weight Watchers reported Q1 2026 revenue of $168 million, down 10% year-over-year, but clinical subscription revenue grew 32% to $39 million.
- End of period clinical subscribers increased 46% year-over-year to 197,000, while total subscribers declined to 2.7 million.
- Company reaffirmed full-year 2026 revenue guidance of $620-$635 million and plans to reduce debt by $42 million through prepayment.
- Adjusted gross margin remained near record highs at 73.6%, despite a mix shift towards lower-margin clinical subscriptions.
- Net loss for the quarter was $52 million, reflecting higher depreciation and amortization costs.
The big picture
Weight Watchers' Q1 2026 results highlight the tension between its growing clinical business and declining behavioral subscriptions. The company's focus on operational efficiencies and debt reduction comes as it navigates a competitive landscape in the weight management industry. The strategic shift towards higher-value clinical offerings and the stabilization of its behavioral business will be key to its long-term success.
What we're watching
- Clinical Growth Sustainability
- Whether Weight Watchers can maintain its 46% year-over-year growth in clinical subscribers amid increasing competition in the GLP-1 market.
- Behavioral Business Stabilization
- How the company will address the 10% year-over-year decline in behavioral subscription revenue through its Core+ tier.
- Debt Reduction Impact
- The pace at which Weight Watchers can reduce its debt burden and the potential impact on its financial flexibility.
Related topics